As of 9:31 AM EDT. Market Open. In the third quarter of 2024, ILMN is likely to have benefited from the significant step-up in consumables with growing customer activity on NovaSeq X. Illumina ...

Sequencing giant Illumina Inc. ILMN is set to release third-quarter 2024 results on Nov. 4 after the closing bell. Stay up-to ...

RBC Capital analyst Conor McNamara maintained a Buy rating on Illumina (ILMN – Research Report) on October 23 and set a price target of ...

NASDAQ:ILMN ) share price has gained 23% in... The FDA grants orphan drug and rare pediatric disease designations to LBPH's lead pipeline drug for the treatment of Dravet Syndrome. Data from a ...

Shares of Illumina ILMN have been showcasing ... 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops." ...

With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform. Finding good stocks at good prices ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Illumina is listed on the CBOE trading with ticker code ILMN.US. It has a market capitalisation of $22.86b, with approximately 159.30m shares in issue. Over the last year, Illumina share price has ...

These factors contributed to a free fall in ILMN stock from a peak of 510.54 in ... before rebounding to its current price of 141.43. Illumina's revenue growth has clearly disappointed.